本頁面由Tiger Trade Technology Pte. Ltd.提供服務

神經分泌生物科學

150.02
-7.2000-4.58%
盤前150.950.9300+0.62%08:04 EDT
成交量:133.22萬
成交額:2.01億
市值:153.02億
市盈率:21.99
高:156.70
開:156.70
低:149.15
收:157.22
52周最高:186.12
52周最低:122.14
股本:1.02億
流通股本:9,999.56萬
量比:1.50
換手率:1.33%
股息:- -
股息率:- -
每股收益(TTM):6.82
每股收益(LYR):4.67
淨資產收益率:22.09%
總資產收益率:11.70%
市淨率:4.14
市盈率(LYR):32.12

資料載入中...

2021/10/05

SEC問詢函

CORRESP [Cover] - Correspondence
2021/08/18

持股變動聲明

4 - Statement of changes in beneficial ownership of securities
2021/08/03

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/08/03

重要事件披露

8-K - Current report
2021/05/21

重要事件披露

8-K - Current report
2021/05/05

重要事件披露

8-K - Current report
2021/05/05

季度報告

10-Q - Quarterly report [Sections 13 or 15(d)]
2021/04/16

重要事件披露

8-K - Current report
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/04/12

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/16

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/11

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/10

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/08

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/02/05

年度報告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2021/02/04

重要事件披露

8-K - Current report
2021/02/02

重要事件披露

8-K - Current report
2021/01/29

超過5%披露

SC 13G/A [Amend] - Statement of acquisition of beneficial ownership by individuals
2021/01/08

重要事件披露

8-K - Current report